| Structure-activity relationship of chemical penetration enhan-cers in transdermal drug delivery N Kanikkannan, K Kandimalla, SS Lamba, M Singh Current medicinal chemistry 7 (6), 593-608, 2000 | 425 | 2000 |
| COVID-19 transmission, current treatment, and future therapeutic strategies VS Salian, JA Wright, PT Vedell, S Nair, C Li, M Kandimalla, X Tang, ... Molecular pharmaceutics 18 (3), 754-771, 2021 | 406 | 2021 |
| Gut microbiota-produced tryptamine activates an epithelial G-protein-coupled receptor to increase colonic secretion Y Bhattarai, BB Williams, EJ Battaglioli, WR Whitaker, L Till, M Grover, ... Cell host & microbe 23 (6), 775-785. e5, 2018 | 312 | 2018 |
| A comprehensive analysis of breast cancer microbiota and host gene expression KJ Thompson, JN Ingle, X Tang, N Chia, PR Jeraldo, MR Walther-Antonio, ... PloS one 12 (11), e0188873, 2017 | 134 | 2017 |
| Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer’s disease and cerebral amyloid angiopathy EK Agyare, GL Curran, M Ramakrishnan, CC Yu, JF Poduslo, ... Pharmaceutical research 25, 2674-2684, 2008 | 124 | 2008 |
| Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid β protein KK Kandimalla, OG Scott, S Fulzele, MW Davidson, JF Poduslo PloS one 4 (2), e4627, 2009 | 99 | 2009 |
| In vivo targeting of antibody fragments to the nervous system for Alzheimer’s disease immunotherapy and molecular imaging of amyloid plaques JF Poduslo, M Ramakrishnan, SS Holasek, M Ramirez‐Alvarado, ... Journal of neurochemistry 102 (2), 420-433, 2007 | 97 | 2007 |
| Surface plasmon resonance binding kinetics of Alzheimer’s disease amyloid β peptide-capturing and plaque-binding monoclonal antibodies M Ramakrishnan, KK Kandimalla, TM Wengenack, KG Howell, ... Biochemistry 48 (43), 10405-10415, 2009 | 86 | 2009 |
| Effect of fatty acids on the permeation of melatonin across rat and pig skin in-vitro and on the transepidermal water loss in rats in-vivo K Kandimalla, N Kanikkannan, S Andega, M Singh Journal of pharmacy and pharmacology 51 (7), 783-790, 1999 | 86 | 1999 |
| Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein KM Jaruszewski, S Ramakrishnan, JF Poduslo, KK Kandimalla Nanomedicine: Nanotechnology, Biology and Medicine 8 (2), 250-260, 2012 | 77 | 2012 |
| Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid β protein 40 in wild-type and Alzheimer's disease transgenic mice (APP, PS1) and its implications … KK Kandimalla, GL Curran, SS Holasek, EJ Gilles, TM Wengenack, ... Journal of Pharmacology and Experimental Therapeutics 313 (3), 1370-1378, 2005 | 76 | 2005 |
| Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson’s disease Y Bhattarai, J Si, M Pu, OA Ross, PJ McLean, L Till, W Moor, M Grover, ... Gut Microbes 13 (1), 1866974, 2021 | 75 | 2021 |
| Multimodal Nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain KM Jaruszewski, GL Curran, SK Swaminathan, JT Rosenberg, SC Grant, ... Biomaterials 35 (6), 1967-1976, 2014 | 73 | 2014 |
| Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice SS Holasek, TM Wengenack, KK Kandimalla, C Montano, DM Gregor, ... Brain research 1045 (1-2), 185-198, 2005 | 71 | 2005 |
| Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits EK Agyare, KM Jaruszewski, GL Curran, JT Rosenberg, SC Grant, ... Journal of controlled release 185, 121-129, 2014 | 69 | 2014 |
| Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer’s drug discovery RS Omtri, MW Davidson, B Arumugam, JF Poduslo, KK Kandimalla Molecular pharmaceutics 9 (7), 1887-1897, 2012 | 68 | 2012 |
| Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method KK Kandimalla, N Kanikkannan, M Singh Journal of controlled release 61 (1-2), 71-82, 1999 | 66 | 1999 |
| Selective contrast enhancement of individual Alzheimer’s disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Aβ42 for magnetic … M Ramakrishnan, TM Wengenack, KK Kandimalla, GL Curran, EJ Gilles, ... Pharmaceutical research 25, 1861-1872, 2008 | 64 | 2008 |
| Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice CC Gali, E Fanaee-Danesh, M Zandl-Lang, NM Albrecher, ... Molecular and Cellular Neuroscience 99, 103390, 2019 | 63 | 2019 |
| Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae KK Kandimalla, MD Donovan Pharmaceutical research 22, 1121-1128, 2005 | 60 | 2005 |
Suresh Kumar SwaminathanUniversity of MinnesotaEmail verificata su umn.edu
